# Lactation Inhibition, the Efficiency of Vitamin B6 Versus Cabergoline

> **NCT05024422** · NA · COMPLETED · sponsor: **HaEmek Medical Center, Israel** · enrollment: 89 (actual)

## Conditions studied

- Lactation Suppressed

## Interventions

- **DRUG:** Cabergoline
- **DRUG:** Pyridoxine

## Key facts

- **NCT ID:** NCT05024422
- **Lead sponsor:** HaEmek Medical Center, Israel
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-31
- **Primary completion:** 2022-11-01
- **Final completion:** 2022-11-07
- **Target enrollment:** 89 (ACTUAL)
- **Last updated:** 2022-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05024422

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05024422, "Lactation Inhibition, the Efficiency of Vitamin B6 Versus Cabergoline". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05024422. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*